MACULAR ATROPHY

Clinical trials for MACULAR ATROPHY explained in plain language.

Never miss a new study

Get alerted when new MACULAR ATROPHY trials appear

Sign up with your email to follow new studies for MACULAR ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

First human test of gene injection aims to halt blinding eye disease

Disease control Terminated

This early-stage study tested a new gene therapy called GT005 for people with an advanced form of dry age-related macular degeneration (AMD) that causes vision loss. The therapy involved a single injection into the back of the eye, aiming to deliver a gene that might help control…

Matched conditions: MACULAR ATROPHY

Phase: PHASE1, PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control

Last updated Mar 30, 2026 14:27 UTC

MACULAR ATROPHY

Get alerted when new MACULAR ATROPHY trials appear

First human test of gene injection aims to halt blinding eye disease